Abonnement à la biblothèque: Guest
Critical Reviews™ in Immunology

Publication de 6  numéros par an

ISSN Imprimer: 1040-8401

ISSN En ligne: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Tumor Antigen Presentation by Dendritic Cells

Volume 30, Numéro 4, 2010, pp. 345-386
DOI: 10.1615/CritRevImmunol.v30.i4.30
Get accessGet access

RÉSUMÉ

Tumor cells are generally regarded as poor stimulators of naive T cells. In contrast, dendritic cells (DCs) are highly specialized in this function, and are therefore likely to be important intermediaries in the process of stimulating T cell responses to tumors. While providing solid evidence that DCs participate in antitumor immunity has proved difficult, several lines of evidence point in this direction. First, animal models involving bone marrow chimeras have shown that cells of hematopoeitic origin are required to elicit T cell responses to whole-tumor vaccines. Second, compared with other cells of hematopoeitic origin, DCs are particularly well-equipped to cross-present exogenous antigens to CD8+ T cells, a critical function if intermediary cells are involved. Third, tumor-infiltrating DCs purified from tumor samples have the capacity to cross-present tumor antigens in vitro. Finally, priming of anti-tumor T cell responses can be abrogated in new in vivo models in which DCs can be specifically depleted. It is therefore significant that DCs in cancer patients are often kept in an immature or dysfunctional state, thereby preventing stimulation of tumor-specific T cells. This review describes the different steps required for DCs to elicit T cell responses to tumor-associated antigens, and highlights processes that are amenable to intervention as therapy. We conclude that effective anti-tumor activity may be dependent on the ability to re-program DCs resident in the host, perhaps even when transferred autologous DCs generated ex vivo are used as vaccines. In this context, recruiting the activity of cells of the innate immune system to condition host DCs may help elicit more effective T cell-mediated responses.

CITÉ PAR
  1. Sick E, Jeanne A, Schneider C, Dedieu S, Takeda K, Martiny L, CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest, British Journal of Pharmacology, 167, 7, 2012. Crossref

  2. Ochi Atsuo, Nguyen Andrew H., Bedrosian Andrea S., Mushlin Harry M., Zarbakhsh Saman, Barilla Rocky, Zambirinis Constantinos P., Fallon Nina C., Rehman Adeel, Pylayeva-Gupta Yuliya, Badar Sana, Hajdu Cristina H., Frey Alan B., Bar-Sagi Dafna, Miller George, MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells, Journal of Experimental Medicine, 209, 9, 2012. Crossref

  3. Wen Chih-Chun, Chen Hui-Ming, Yang Ning-Sun, Developing Phytocompounds from Medicinal Plants as Immunomodulators, in Recent Trends in Medicinal Plants Research, 62, 2012. Crossref

  4. Jarry Ulrich, Jeannin Pascale, Pineau Laurent, Donnou Sabrina, Delneste Yves, Couez Dominique, Efficiently stimulated adult microglia cross-prime naive CD8+T cells injected in the brain, European Journal of Immunology, 43, 5, 2013. Crossref

  5. Cirone Mara, Garufi Alessia, Di Renzo Livia, Granato Marisa, Faggioni Alberto, D’Orazi Gabriella, Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells, OncoImmunology, 2, 9, 2013. Crossref

  6. Rosalia Rodney A., Silva Ana Luisa, Camps Marcel, Allam Ahmed, Jiskoot Wim, van der Burg Sjoerd H., Ossendorp Ferry, Oostendorp Jaap, Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles, Cancer Immunology, Immunotherapy, 62, 7, 2013. Crossref

  7. Zhang Zhuoli, Li Weiguo, Procissi Daniele, Li Kangan, Sheu Alexander Y., Gordon Andrew C., Guo Yang, Khazaie Khashayarsha, Huan Yi, Han Guohong, Larson Andrew C., Antigen-loaded Dendritic Cell Migration: MR Imaging in a Pancreatic Carcinoma Model, Radiology, 274, 1, 2015. Crossref

  8. Dong Baijun, Minze Laurie J, Xue Wei, Chen Wenhao, Molecular insights into the development of T cell-based immunotherapy for prostate cancer, Expert Review of Clinical Immunology, 10, 11, 2014. Crossref

  9. Aguilar-Cazares Dolores, Meneses-Flores Manuel, Prado-Garcia Heriberto, Islas-Vazquez Lorenzo, Rojo-Leon Veronica, Romero-Garcia Susana, Rivera-Rosales Rosa M., Lopez-Gonzalez Jose S., Relationship of Dendritic Cell Density, HMGB1 Expression, and Tumor-infiltrating Lymphocytes in Non–Small Cell Lung Carcinomas, Applied Immunohistochemistry & Molecular Morphology, 22, 2, 2014. Crossref

  10. Kobukai Saho, Kremers Gert-Jan, Cobb Jared G., Baheza Richard, Xie Jingping, Kuley Alex, Zhu Meiying, Pham Wellington, Induction of Antitumor Immunity by Dendritic Cells Loaded with Membrane-Translocating Mucin 1 Peptide Antigen, Translational Oncology, 4, 1, 2011. Crossref

  11. Ito Toshihiro, Carson William F., Cavassani Karen A., Connett Judith M., Kunkel Steven L., CCR6 as a mediator of immunity in the lung and gut, Experimental Cell Research, 317, 5, 2011. Crossref

  12. Ponce Rafael A., Promises and Challenges with Immunomodulatory Biologics, in Molecular Immunotoxicology, 2014. Crossref

  13. Gasparini Chiara, Tommasini Alberto, Zauli Giorgio, The MDM2 inhibitor Nutlin-3 modulates dendritic cell–induced T cell proliferation, Human Immunology, 73, 4, 2012. Crossref

  14. Allen Clint T., Judd Nancy P., Bui Jack D., Uppaluri Ravindra, The clinical implications of antitumor immunity in head and neck cancer, The Laryngoscope, 122, 1, 2012. Crossref

  15. Sampson John H., Mitchell Duane A., Vaccination strategies for neuro-oncology: Table 1., Neuro-Oncology, 17, suppl 7, 2015. Crossref

  16. Chandrasekaran Siddarth, King Michael, Microenvironment of Tumor-Draining Lymph Nodes: Opportunities for Liposome-Based Targeted Therapy, International Journal of Molecular Sciences, 15, 11, 2014. Crossref

  17. Cirone Mara, Di Renzo Livia, Lotti Lavinia Vittoria, Conte Valeria, Trivedi Pankaj, Santarelli Roberta, Gonnella Roberta, Frati Luigi, Faggioni Alberto, Busson Pierre, Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91, PLoS ONE, 7, 3, 2012. Crossref

  18. Perche Federico, Torchilin Vladimir P., Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting, Journal of Drug Delivery, 2013, 2013. Crossref

  19. Jara Evelyn L., Muñoz-Durango Natalia, Llanos Carolina, Fardella Carlos, González Pablo A., Bueno Susan M., Kalergis Alexis M., Riedel Claudia A., Modulating the function of the immune system by thyroid hormones and thyrotropin, Immunology Letters, 184, 2017. Crossref

  20. Baroja-Mazo Alberto, Barberà-Cremades Maria, Pelegrín Pablo, Idzko Marco, P2X7 Receptor Activation Impairs Exogenous MHC Class I Oligopeptides Presentation in Antigen Presenting Cells, PLoS ONE, 8, 8, 2013. Crossref

  21. Riccione K.A., Gedeon P., Sanchez-Perez L., Sampson J.H., Checkpoint Blockade Immunotherapy for Glioblastoma, in Translational Immunotherapy of Brain Tumors, 2017. Crossref

  22. Strioga Marius, Schijns Virgil, Powell Daniel J, Pasukoniene Vita, Dobrovolskiene Neringa, Michalek Jaroslav, Dendritic cells and their role in tumor immunosurveillance, Innate Immunity, 19, 1, 2013. Crossref

  23. Lybaert Lien, Vermaelen Karim, De Geest Bruno G., Nuhn Lutz, Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity, Journal of Controlled Release, 289, 2018. Crossref

  24. Kroll Ashley V., Jiang Yao, Zhou Jiarong, Holay Maya, Fang Ronnie H., Zhang Liangfang, Biomimetic Nanoparticle Vaccines for Cancer Therapy, Advanced Biosystems, 3, 1, 2019. Crossref

  25. Mirsoian Annie, Sckisel Gail D., Zamora Anthony E., Murphy William J., Impact of Obesity and Aging on the Tumor Immuno-Environment, in The Tumor Immunoenvironment, 2013. Crossref

  26. Fleet J.C., Burcham G.N., Calvert R.D., Elzey B.D., Ratliff T.L., 1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC), The Journal of Steroid Biochemistry and Molecular Biology, 198, 2020. Crossref

  27. Ghosh Mallika, McAuliffe Beata, Subramani Jaganathan, Basu Sreyashi, Shapiro Linda H., CD13 Regulates Dendritic Cell Cross-Presentation and T Cell Responses by Inhibiting Receptor-Mediated Antigen Uptake, The Journal of Immunology, 188, 11, 2012. Crossref

  28. Fotin-Mleczek Mariola, Zanzinger Kai, Heidenreich Regina, Lorenz Christina, Kowalczyk Aleksandra, Kallen Karl-Josef, Huber Stephan M, mRNA-based vaccines synergize with radiation therapy to eradicate established tumors, Radiation Oncology, 9, 1, 2014. Crossref

  29. Zhang Bin, Dong Yuhao, Liu Jing, Lian Zhouyang, Liang Long, Chen Wenbo, Luo Xiaoning, Pei Shufang, Mo Xiaokai, Zhang Lu, Huang Wenhui, Ouyang Fusheng, Guo Baoliang, Liang Changhong, Zhang Shuixing, Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment, Oncotarget, 8, 4, 2017. Crossref

  30. Gedeon Patrick C., Champion Cosette D., Rhodin Kristen E., Woroniecka Karolina, Kemeny Hanna R., Bramall Alexa N., Bernstock Joshua D., Choi Bryan D., Sampson John H., Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook, Expert Review of Clinical Pharmacology, 13, 10, 2020. Crossref

  31. Cheng Chun-Chia, Lin Hsin-Chi, Chiang Ya-Wen, Chang Jungshan, Sie Zong-Lin, Yang Bi-Ling, Lim Ken-Hong, Peng Cheng-Liang, Ho Ai-Sheng, Chang Yi-Fang, Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression, Cancer Immunology, Immunotherapy, 70, 5, 2021. Crossref

  32. Wang Ke, Chen Ruo, Feng Zhuan, Zhu Yu-Meng, Sun Xiu-Xuan, Huang Wan, Chen Zhi-Nan, Identification of differentially expressed genes in non-small cell lung cancer, Aging, 11, 23, 2019. Crossref

  33. Wen Chih-Chun, Chen Hui-Ming, Chen Swey-Shen, Huang Li-Ting, Chang Wei-Ting, Wei Wen-Chi, Chou Li-Chen, Arulselvan Palanisamy, Wu Jin-Bin, Kuo Sheng-Chu, Yang Ning-Sun, Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines, Journal of Biomedical Science, 18, 1, 2011. Crossref

  34. Shindo Yoshitaro, Hazama Shoichi, Maeda Yoshinari, Matsui Hiroto, Iida Michihisa, Suzuki Nobuaki, Yoshimura Kiyoshi, Ueno Tomio, Yoshino Shigefumi, Sakai Kohei, Suehiro Yutaka, Yamasaki Takahiro, Hinoda Yuji, Oka Masaaki, Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer, Journal of Translational Medicine, 12, 1, 2014. Crossref

  35. Zhang Yu, Lin Shuibin, Wang Xiang‐Yang, Zhu Guizhi, Nanovaccines for cancer immunotherapy, WIREs Nanomedicine and Nanobiotechnology, 11, 5, 2019. Crossref

  36. Hennies C M, Reboulet R A, Garcia Z, Nierkens S, Wolkers M C, Janssen E M, Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo , Clinical and Experimental Immunology, 163, 3, 2011. Crossref

  37. Dang Yushe, Wagner Wolfgang M., Gad Ekram, Rastetter Lauren, Berger Carmen M., Holt Gregory E., Disis Mary L., Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells, Clinical Cancer Research, 18, 11, 2012. Crossref

  38. Keshavarz-Fathi Mahsa, Keshavarz-Fathi Mahdis, Rezaei Nima, Cancer Immunology, in Encyclopedia of Infection and Immunity, 2022. Crossref

  39. Theobald Matthias, Brossart Peter, Seliger Barbara, Grundlagen der Tumorimmunologie, in Kompendium Internistische Onkologie, 2022. Crossref

  40. Dolganiuc Angela, Szabo Gyongyi, Dendritic cells in hepatitis C infection: can they (help) win the battle?, Journal of Gastroenterology, 46, 4, 2011. Crossref

  41. Younis Muhsin H., Tang Zhongmin, Cai Weibo, Multimodality imaging of nanoparticle‐based vaccines: Shedding light on immunology , WIREs Nanomedicine and Nanobiotechnology, 14, 5, 2022. Crossref

Prochains articles

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain